Deborah Kaplan

​The coronavirus public health emergency may have ended last year, but its effects on the pharmaceutical industry continue to reverberate.
Like during the pandemic, drug and medical supply shortages continue to plague the industry. While the federal government investigates the issue, public and private entities continue to push for increased visibility and collaboration.
drug shortages, DSCSA, drug supply chain security act, regulations

What do herring fishers have to do with drug approvals and Medicare payment policies? If they win their cases in the Supreme Court, the herring fisheries could eliminate or reduce the courts’ reliance on the Chevron deference, ushering in more lawsuits against federal agencies on healthcare issues.

On one filling line each day, Medivant Healthcare produces 20,000 single dose injectable vials. These vials end up at patient bedsides, on hospital crash carts and in the emergency room, often for patients needing an anesthetic.
AI, manufacturing, pharmaceuticals, artificial intelligence

GE Healthcare’s iodine-recycling program is expanding throughout Europe and the Americas.
When Northumberland Hills Hospital in Ontario, Canada, started collecting unused iodine-based contrast media to recycle, the staff had no idea iodine recycling was even possible. “We’re always looking for initiatives to make ourselves greener,” says Ian Moffat, Northumberland’s director of diagnostic imaging and laboratory services, and this turned out to be an easy addition to their sustainability progr...

Hospitals don’t usually have electrical engineers or a chief scientific officer. Children’s Hospital of Orange County has both – and it’s paying off for the patients.
research, medical system, healthcare, pediatrics, academic medical system

Healthcare still lags on digitization compared to other sectors, not only in spending but in the use of tech for business processes and payments. Change is coming to the industry, but data regulatory requirements, a complex stakeholder ecosystem and a reliance on outdated legacy systems have slowed progress.
“That complexity is very special to healthcare [and] that is also where the opportunity for digitization lies,” says Max Neukirchen, head of payments and commerce solutions at J.P. Morgan...

Celebrating the 2023 Member Recognition Award recipients for their inspiring work
Each year, HealthTrust’s Member Recognition Awards honor members leading initiatives that bring their organizations to new heights of performance. This year’s awards, given at the annual HealthTrust University Conference in Las Vegas, highlight group and facility efforts for improving health measures, enhancing the clinician and patient experience, and better sustaining our environment.

Key takeaways from HTU’s Executive Pharmacy Exchange
Data analytics, workforce challenges and pharmacist leadership are key areas of interest for managing today’s pharmaceutical enterprise. These topics were covered in the Executive Pharmacy Exchange panel discussion at the HealthTrust University Conference in July.

Mitigating emergencies & threats with technology
Hospital and health system disasters and other emergencies rely on technology and tools for mitigation. They depend on real-time information which can affect clinical care, available supplies, staffing and equipment.

From cashless transactions harnessing biometrics to mobile wallets, digital payments are enhancing global connectivity and transforming how we shop and spend. The impact is huge: digital payment transactions are valued at $9.46 trillion in 2023 alone. This progress cannot be untethered from rapid change affecting the tech industry. While tech companies fend off economic headwinds, executives still view investing in digital transformation as integral to survival.